BANK VONTOBEL/CALL/MERCK & CO./130/0.1/20.12.24 | Real-time Boerse Frankfurt Warrants 01:52:15 2024-05-17 pm EDT | ||
| 0.89 EUR | -1.11% |
|
| 1 month | +23.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.89 | -1.11% |
| 24-05-16 | 0.9 | -2.17% |
| 24-05-15 | 0.92 | +21.05% |
| 24-05-14 | 0.76 | -1.30% |
| 24-05-13 | 0.77 | -12.50% |
Real-time Boerse Frankfurt Warrants
Last update May 17, 2024 at 01:52 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VD3SE5 |
| ISIN | DE000VD3SE55 |
| Date issued | 2024-04-09 |
| Strike | 130 $ |
| Maturity | 2024-12-20 (215 Days) |
| Parity | 10 : 1 |
| Emission price | 0.78 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.02 € |
|---|---|
| Lowest since issue | 0.69 € |
| Spread | 0.05 € |
| Spread % | 5.26% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2
USD
Average target price
141.6
USD
Spread / Average Target
+7.96%
- Stock Market
- Warrants
- Warrant
